טוען...
Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(−/−) mice
BACKGROUND AND PURPOSE: Atherosclerosis is characterized by a chronic non‐resolving inflammation in the arterial wall. Aspirin‐triggered lipoxin A4 (ATL) is a potent anti‐inflammatory mediator, involved in the resolution of inflammation. However, the therapeutic potential of immune targeting by mean...
שמור ב:
| הוצא לאור ב: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659998/ https://ncbi.nlm.nih.gov/pubmed/28071789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13707 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|